Burkly Linda

Track

Insider profile

Performance

Overall performance
4.1
Performance over holding periods
4.1
30 days 90 days 120 days
Average return 20% 8.2% 15.1%
Success rate 95% 68% 82%
Transactions
7 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Burkly Linda's trades of Editas Medicine Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-21 2026-07-27
PrS Proposed sale
90,580
494.30
US$2,810,160 		90,580 494.30 US$2,810,160
2026-06-05 2026-06-03
S Sale
91,644 -17.9%
116.21
US$4,715,356 		91,644 -17.9% 116.21 US$4,715,356
2026-03-04 2026-03-03
S Sale
16,814 -29.4%
118.89
US$969,316 		16,814 -29.4% 118.89 US$969,316
2025-12-04 2025-12-03
S Sale
713 -1.0%
2.15
US$1,535 		713 -1.0% 2.15 US$1,535
2025-09-04 2025-09-03
PlS Planned sale
710 -1.0%
2.60
US$1,843 		710 -1.0% 2.60 US$1,843
2025-08-29 2025-09-03
PrS Proposed sale
800
2.73
US$2,184 		800 2.73 US$2,184
2025-08-04 2025-07-31
S Sale
5,121 -7.4%
2.49
US$12,757 		5,121 -7.4% 2.49 US$12,757
2025-07-30 2025-07-31
PrS Proposed sale
7,500
3.46
US$25,950 		7,500 3.46 US$25,950
2025-06-04 2025-06-03
S Sale
726 -1.0%
1.72
US$1,252 		726 -1.0% 1.72 US$1,252
2025-03-05 2025-03-04
S Sale
2,891 -4.0%
1.71
US$4,946 		2,891 -4.0% 1.71 US$4,946
2025-02-28 2025-03-03
PrS Proposed sale
6,000
1.86
US$11,160 		6,000 1.86 US$11,160
2024-07-26 2024-07-25
S Sale
11,886 -14.0%
5.42
US$64,370 		11,886 -14.0% 5.42 US$64,370
2024-07-18 2024-07-25
PrS Proposed sale
26,000
5.61
US$145,860 		26,000 5.61 US$145,860